The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Abstract
Acute myeloid leukemia (AML) is a malignant disorder of the bone marrow which is characterized by the clonal expansion and differentiation arrest of myeloid progenitor cells. The age-adjusted incidence of AML is 4.3 per 100,000 annually in the United States (US). Incidence increases with age with a median age at diagnosis of 68 years in the US. The etiology of AML is heterogeneous. In some patients, prior exposure to therapeutic, occupational or environmental DNA-damaging agents is implicated, but most cases of AML remain without a clear etiology. AML is the most common form of acute leukemia in adults and has the shortest survival (5-year survival = 24%). Curative therapies, including intensive chemotherapy and allogeneic stem cell transplantation, are generally applicable to a minority of patients who are younger and fit, while most older individuals exhibit poor prognosis and survival. Differences in patient outcomes are influenced by disease characteristics, access to care including active therapies and supportive care, and other factors. After many years without therapeutic advances, several new therapies have been approved and are expected to impact patient outcomes, especially for older patients and those with refractory disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016) · Blood · doi:10.1182/blood-2016-03-643544 · Cited by 10,119
Döhner, H., Estey, E., Grimwade, D., Amadori, S., Appelbaum, F. R., Büchner, T., Dombret, H., Ebert, B. L., Fenaux, P., Larson, R. A., et al. (2017) · Blood · doi:10.1182/blood-2016-08-733196 · Cited by 5,775
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Vardiman, J. W., Thiele, J., Arber, D. A., Brunning, R. D., Borowitz, M. J., Porwit, A., Harris, N. L., Le Beau, M. M., Hellström-Lindberg, E., Tefferi, A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-209262 · Cited by 4,424
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
Stone, R. M., Mandrekar, S. J., Sanford, B. L., Laumann, K., Geyer, S., Bloomfield, C. D., Thiede, C., Prior, T. W., Döhner, K., Marcucci, G., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614359 · Cited by 2,250
DiNardo, C. D., Pratz, K., Pullarkat, V., Jonas, B. A., Arellano, M., Becker, P. S., Frankfurt, O., Konopleva, M., Wei, A. H., Kantarjian, H. M., et al. (2019) · Blood · doi:10.1182/blood-2018-08-868752 · Cited by 1,825
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Stein, E. M., DiNardo, C. D., Pollyea, D. A., Fathi, A. T., Roboz, G. J., Altman, J. K., Stone, R. M., DeAngelo, D. J., Levine, R. L., Flinn, I. W., et al. (2017) · Blood · doi:10.1182/blood-2017-04-779405 · Cited by 1,516
Durable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML
DiNardo, C. D., Stein, E. M., de Botton, S., Roboz, G. J., Altman, J. K., Mims, A. S., Swords, R., Collins, R. H., Mannis, G. N., Pollyea, D. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716984 · Cited by 1,454
Age and acute myeloid leukemia
Appelbaum, F. R., Gundacker, H., Head, D. R., Slovak, M. L., Willman, C. L., Godwin, J. E., Anderson, J. E., & Petersdorf, S. H. (2006) · Blood · doi:10.1182/blood-2005-09-3724 · Cited by 1,350
‘Acute myeloid leukemia: a comprehensive review and 2016 update’
De Kouchkovsky, I., & Abdul-Hay, M. (2016) · Blood Cancer Journal · doi:10.1038/bcj.2016.50 · Cited by 1,317
Lancet, J. E., Uy, G. L., Cortes, J. E., Newell, L. F., Lin, T. L., Ritchie, E. K., Stuart, R. K., Strickland, S. A., Hogge, D., Solomon, S. R., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6112 · Cited by 1,025
Juliusson, G., Antunovic, P., Derolf, Å., Lehmann, S., Möllgård, L., Stockelberg, D., Tidefelt, U., Wahlin, A., & Höglund, M. (2009) · Blood · doi:10.1182/blood-2008-07-172007 · Cited by 987
Risks of leukaemia and solid tumours in individuals with Down's syndrome
Hasle, H., Clemmensen, I. H., & Mikkelsen, M. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05264-2 · Cited by 892
Hills, R. K., Castaigne, S., Appelbaum, F. R., Delaunay, J., Petersdorf, S., Othus, M., Estey, E. H., Dombret, H., Chevret, S., Ifrah, N., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70281-5 · Cited by 721
Smith, A., Howell, D., Patmore, R., Jack, A., & Roman, E. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.450 · Cited by 692
Smith, S. M., Le Beau, M. M., Huo, D., Karrison, T., Sobecks, R. M., Anastasi, J., Vardiman, J. W., Rowley, J. D., & Larson, R. A. (2003) · Blood · doi:10.1182/blood-2002-11-3343 · Cited by 682
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
O'Donnell, M. R., Tallman, M. S., Abboud, C. N., Altman, J. K., Appelbaum, F. R., Arber, D. A., Bhatt, V., Bixby, D., Blum, W., Coutre, S. E., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0116 · Cited by 654
Hematotoxicity in Workers Exposed to Low Levels of Benzene
Lan, Q., Zhang, L., Li, G., Vermeulen, R., Weinberg, R. S., Dosemeci, M., Rappaport, S. M., Shen, M., Alter, B. P., Wu, Y., et al. (2004) · Science · doi:10.1126/science.1102443 · Cited by 647
Acute myeloid leukemia: Epidemiology and etiology
Deschler, B., & Lübbert, M. (2006) · Cancer · doi:10.1002/cncr.22233 · Cited by 646
Dores, G. M., Devesa, S. S., Curtis, R. E., Linet, M. S., & Morton, L. M. (2012) · Blood · doi:10.1182/blood-2011-04-347872 · Cited by 636
Somatic mutations precede acute myeloid leukemia years before diagnosis
Desai, P., Mencia-Trinchant, N., Savenkov, O., Simon, M. S., Cheang, G., Lee, S., Samuel, M., Ritchie, E. K., Guzman, M. L., Ballman, K. V., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0081-z · Cited by 619
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
Kutler, D. I., Singh, B., Satagopan, J., Batish, S. D., Berwick, M., Giampietro, P. F., Hanenberg, H., & Auerbach, A. D. (2003) · Blood · doi:10.1182/blood-2002-07-2170 · Cited by 618
Hahn, C. N., Chong, C.-E., Carmichael, C. L., Wilkins, E. J., Brautigan, P. J., Li, X.-C., Babic, M., Lin, M., Carmagnac, A., Lee, Y. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.913 · Cited by 606
Biology and relevance of human acute myeloid leukemia stem cells
Thomas, D., & Majeti, R. (2017) · Blood · doi:10.1182/blood-2016-10-696054 · Cited by 500
Cortes, J. E., Heidel, F. H., Hellmann, A., Fiedler, W., Smith, B. D., Robak, T., Montesinos, P., Pollyea, D. A., DesJardins, P., Ottmann, O., et al. (2019) · Leukemia · doi:10.1038/s41375-018-0312-9 · Cited by 496
Perl, A. E., Altman, J. K., Cortes, J., Smith, C., Litzow, M., Baer, M. R., Claxton, D., Erba, H. P., Gill, S., Goldberg, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30416-3 · Cited by 490
Cancer in dyskeratosis congenita
Alter, B. P., Giri, N., Savage, S. A., & Rosenberg, P. S. (2009) · Blood · doi:10.1182/blood-2008-12-192880 · Cited by 478
Granfeldt Østgård, L. S., Medeiros, B. C., Sengeløv, H., Nørgaard, M., Andersen, M. K., Dufva, I. H., Friis, L. S., Kjeldsen, E., Marcher, C. W., Preiss, B., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0890 · Cited by 451
Acute Leukemia after Alkylating-Agent Therapy of Ovarian Cancer
Reimer, R. R., Hoover, R., Fraumeni, J. F., & Young, R. C. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707282970402 · Cited by 448
Risk of Leukemia after Chemotherapy and Radiation Treatment for Breast Cancer
Curtis, R. E., Boice, J. D., Stovall, M., Bernstein, L., Greenberg, R. S., Flannery, J. T., Schwartz, A. G., Weyer, P., Moloney, W. C., & Hoover, R. N. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262605 · Cited by 446
Fanconi anaemia and cancer: an intricate relationship
Nalepa, G., & Clapp, D. W. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.116 · Cited by 389
Taskesen, E., Bullinger, L., Corbacioglu, A., Sanders, M. A., Erpelinck, C. A. J., Wouters, B. J., van der Poel-van de Luytgaarde, S. C., Damm, F., Krauter, J., Ganser, A., et al. (2011) · Blood · doi:10.1182/blood-2010-09-307280 · Cited by 384
Severe congenital neutropenias
Skokowa, J., Dale, D. C., Touw, I. P., Zeidler, C., & Welte, K. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.32 · Cited by 383
McHale, C. M., Zhang, L., & Smith, M. T. (2012) · Carcinogenesis · doi:10.1093/carcin/bgr297 · Cited by 345
Alter, B. P., Giri, N., Savage, S. A., Peters, J. A., Loud, J. T., Leathwood, L., Carr, A. G., Greene, M. H., & Rosenberg, P. S. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08212.x · Cited by 324
Brown, L. M., Blair, A. E., Gibson, R. W., Everett, G. D., Cantor, K. P., Schuman, L. M., Burmeister, L. F., Lier, S. F. V., & Dick, F. R. (1990) · PubMed · Cited by 312
Vlachos, A., Rosenberg, P. S., Atsidaftos, E., Alter, B. P., & Lipton, J. M. (2012) · Blood · doi:10.1182/blood-2011-08-375972 · Cited by 309
Christiansen, D. H., Andersen, M. K., & Pedersen-Bjergaard, J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1405 · Cited by 308
Acute myeloid leukemia in the real world: why population-based registries are needed
Juliusson, G., Lazarevic, V., Hörstedt, A.-S., Hagberg, O., & Höglund, M. (2012) · Blood · doi:10.1182/blood-2011-12-379008 · Cited by 305
Smith, R. E., Bryant, J., DeCillis, A., & Anderson, S. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.114 · Cited by 300
Muffly, L., Pasquini, M. C., Martens, M., Brazauskas, R., Zhu, X., Adekola, K., Aljurf, M., Ballen, K. K., Bajel, A., Baron, F., et al. (2017) · Blood · doi:10.1182/blood-2017-03-772368 · Cited by 297
Noris, P., Perrotta, S., Seri, M., Pecci, A., Gnan, C., Loffredo, G., Pujol-Moix, N., Zecca, M., Scognamiglio, F., De Rocco, D., et al. (2011) · Blood · doi:10.1182/blood-2011-02-336537 · Cited by 295
The incidence of secondary leukemias.
Leone, G. G. M., Mele, L., b, A. P., et al. (1999) · PubMed · Cited by 292
Goldberg, S. L., Chen, E., Corral, M., Guo, A., Mody-Patel, N., Pecora, A. L., & Laouri, M. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.2395 · Cited by 289
Schoch, C., Kern, W., Schnittger, S., Hiddemann, W., & Haferlach, T. (2004) · Leukemia · doi:10.1038/sj.leu.2403187 · Cited by 284
Gaidzik, V. I., Teleanu, V, Papaemmanuil, E., Weber, D., Paschka, P., Hahn, J., Wallrabenstein, T., Kolbinger, B., Köhne, C. H., Horst, H. A., et al. (2016) · Leukemia · doi:10.1038/leu.2016.126 · Cited by 279
Hulegårdh, E., Nilsson, C., Lazarevic, V., Garelius, H., Antunovic, P., Rangert Derolf, Å., Möllgård, L., Uggla, B., Wennström, L., Wahlin, A., et al. (2015) · American Journal of Hematology · doi:10.1002/ajh.23908 · Cited by 269
Rosenberg, P. S., Zeidler, C., Bolyard, A. A., Alter, B. P., Bonilla, M. A., Boxer, L. A., Dror, Y., Kinsey, S., Link, D. C., Newburger, P. E., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08216.x · Cited by 265
Schnittger, S., Dicker, F., Kern, W., Wendland, N., Sundermann, J., Alpermann, T., Haferlach, C., & Haferlach, T. (2011) · Blood · doi:10.1182/blood-2009-11-255976 · Cited by 265
Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition
Cunniff, C., Bassetti, J. A., & Ellis, N. A. (2017) · Molecular Syndromology · doi:10.1159/000452082 · Cited by 265
Natural history of GATA1 mutations in Down syndrome
Ahmed, M. (2004) · Blood · doi:10.1182/blood-2003-10-3383 · Cited by 244
Owen, C. J., Toze, C. L., Koochin, A., Forrest, D. L., Smith, C. A., Stevens, J. M., Jackson, S. C., Poon, M.-C., Sinclair, G. D., Leber, B., et al. (2008) · Blood · doi:10.1182/blood-2008-05-156745 · Cited by 242
Trends in leukemia incidence and survival in the United States (1973–1998)
Xie, Y., Davies, S. M., Xiang, Y., Robison, L. L., & Ross, J. A. (2003) · Cancer · doi:10.1002/cncr.11316 · Cited by 234
Cogle, C. R., Craig, B. M., Rollison, D. E., & List, A. F. (2011) · Blood · doi:10.1182/blood-2011-02-337964 · Cited by 222
Pasquet, M., Bellanné-Chantelot, C., Tavitian, S., Prade, N., Beaupain, B., LaRochelle, O., Petit, A., Rohrlich, P., Ferrand, C., Van Den Neste, E., et al. (2013) · Blood · doi:10.1182/blood-2012-08-447367 · Cited by 217
Zhang, L., Tang, X., Rothman, N., Vermeulen, R., Ji, Z., Shen, M., Qiu, C., Guo, W., Liu, S., Reiss, B., et al. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0762 · Cited by 213
Pesatori, A. C., Consonni, D., Rubagotti, M., Grillo, P., & Bertazzi, P. A. (2009) · Environmental Health · doi:10.1186/1476-069x-8-39 · Cited by 206
Roberts, I., Alford, K., Hall, G., Juban, G., Richmond, H., Norton, A., Vallance, G., Perkins, K., Marchi, E., McGowan, S., et al. (2013) · Blood · doi:10.1182/blood-2013-07-515148 · Cited by 203
Pabst, T., Eyholzer, M., Haefliger, S., Schardt, J., & Mueller, B. U. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5563 · Cited by 201
Zeidan, A. M., Shallis, R. M., Wang, R., Davidoff, A., & Ma, X. (2019) · Blood Reviews · doi:10.1016/j.blre.2018.09.001 · Cited by 196
Self-citationvan Leeuwen, F. E., Chorus, A. M., van den Belt-Dusebout, A. W., Hagenbeek, A., Noyon, R., van Kerkhoff, E. H., Pinedo, H. M., & Somers, R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.5.1063 · Cited by 189
ANKRD26-related thrombocytopenia and myeloid malignancies
Noris, P., Favier, R., Alessi, M.-C., Geddis, A. E., Kunishima, S., Heller, P. G., Giordano, P., Niederhoffer, K. Y., Bussel, J. B., Podda, G. M., et al. (2013) · Blood · doi:10.1182/blood-2013-04-499319 · Cited by 182
Pedersen-Bjergaard, J., Philip, P., Larsen, S. O., Andersson, M. V., Daugaard, G., Ersbøll, J., Sw, H., HOU-JENSEN, K., Nielsen, D. L., & Sigsgaard, T. (1993) · PubMed · Cited by 181
Douer, D., Preston-Martin, S., Chang, E., Nichols, P., Watkins, K., & Levine, A. (1996) · Blood · doi:10.1182/blood.v87.1.308.308 · Cited by 179
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
Jongmans, M. C. J., van der Burgt, I., Hoogerbrugge, P. M., Noordam, K., Yntema, H. G., Nillesen, W. M., Kuiper, R. P., Ligtenberg, M. J., van Kessel, A. G., van Krieken, J. H. J., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.37 · Cited by 178
Gupta, V., Tallman, M. S., & Weisdorf, D. J. (2011) · Blood · doi:10.1182/blood-2010-10-265603 · Cited by 178
Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update
Bhatnagar, N., Nizery, L., Tunstall, O., Vyas, P., & Roberts, I. (2016) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-016-0338-x · Cited by 161
Familial myelodysplastic syndromes: a review of the literature
Liew, E., & Owen, C. (2011) · Haematologica · doi:10.3324/haematol.2011.043422 · Cited by 158
Ratain, M. J., & Rowley, J. D. (1992) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058121 · Cited by 156
Access to hematopoietic stem cell transplantation: Effect of race and sex
Joshua, T. V., Rizzo, J. D., Zhang, M., Hari, P., Kurian, S., Pasquini, M. C., Majhail, N. S., Lee, S. J., & Horowitz, M. M. (2010) · Cancer · doi:10.1002/cncr.25297 · Cited by 148
Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome
Austin, K. M., Gupta, M. L., Coats, S. A., Tulpule, A., Mostoslavsky, G., Balazs, A. B., Mulligan, R. C., Daley, G. Q., Pellman, D. S., & Shimamura, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33764 · Cited by 140
Wolff, A. C., Blackford, A. L., Visvanathan, K., Rugo, H. S., Moy, B., Goldstein, L. J., Stockerl-Goldstein, K. E., Neumayer, L. A., Langbaum, T. S., Theriault, R. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.6119 · Cited by 140
Eichenauer, D. A., Thielen, I., Haverkamp, H., Franklin, J. G., Behringer, K., Halbsguth, T. V., Klimm, B. C., Diehl, V., Sasse, S., Rothe, A., et al. (2014) · Blood · doi:10.1182/blood-2013-07-512657 · Cited by 139
Acute myeloid leukaemia: challenges and real world data from India
Philip, C. C., George, B., Ganapule, A., Korula, A., Jain, P. L., Alex, A. A., Lakshmi, K. M., Sitaram, U., Abubacker, F. N., Abraham, A., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13406 · Cited by 133
SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies
Davidsson, J., Puschmann, A., Tedgård, U., Bryder, D., Nilsson, L., & Cammenga, J. (2018) · Leukemia · doi:10.1038/s41375-018-0074-4 · Cited by 129
Fircanis, S., Merriam, P. A., Khan, N., & Castillo, J. J. (2014) · American Journal of Hematology · doi:10.1002/ajh.23744 · Cited by 126
Ok, C. Y., Patel, K. P., Garcia‐Manero, G., Routbort, M. J., Fu, B., Tang, G., Goswami, M., Singh, R. R., Kanagal‐Shamanna, R., Pierce, S. A., et al. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.12.006 · Cited by 125
Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis
Boddu, P., Kantarjian, H. M., Garcia-Manero, G., Ravandi, F., Verstovsek, S., Jabbour, E., Borthakur, G., Konopleva, M., Bhalla, K. N., Daver, N., et al. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017008227 · Cited by 112
Song, X., Ye, P., Wang, X., Chen, Y., Jin, L., Yang, T., Qian, M., Ni, W., Tong, X., & Lan, J. (2018) · Acta Haematologica · doi:10.1159/000486228 · Cited by 110
Inherited Predisposition to Acute Myeloid Leukemia
Godley, L. A. (2014) · Seminars in Hematology · doi:10.1053/j.seminhematol.2014.08.001 · Cited by 107
Pulte, D. D., Redaniel, M. T., Jansen, L., Brenner, H., & Jeffreys, M. (2012) · Haematologica · doi:10.3324/haematol.2012.063602 · Cited by 104
Myeloid Leukemia in Down Syndrome
Khan, I., Malinge, S., & Crispino, J. D. (2011) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v16.i1-2.40 · Cited by 102
Koontz, M. Z., Horning, S. J., Balise, R. R., Greenberg, P. L., Rosenberg, S. A., Hoppe, R. T., & Advani, R. H. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.5791 · Cited by 100
A review and meta-analysis of formaldehyde exposure and leukemia
Collins, J. J., & Lineker, G. A. (2004) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2004.04.006 · Cited by 98
Germline ETV6 mutations and predisposition to hematological malignancies
Feurstein, S. K., & Godley, L. A. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2259-4 · Cited by 97
Cancer prevalence in the UK: results from the EUROPREVAL study
Forman, D., Stockton, D., Møller, H., et al. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg169 · Cited by 93
Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes
Poynter, J. N., Richardson, M. R., Blair, C. K., Roesler, M. A., Hirsch, B. A., Nguyen, P., Cioc, A. M., Warlick, E. D., Cerhan, J. R., & Ross, J. A. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.12.005 · Cited by 89
Jabo, B., Morgan, J. W., Martı́nez, M. E., Ghamsary, M. G., & Wieduwilt, M. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174760 · Cited by 89
Ganly, P. S., Walker, L. C., & Morris, C. M. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000139611 · Cited by 87
How Do Differences in Treatment Impact Racial and Ethnic Disparities in Acute Myeloid Leukemia?
Patel, M. I., Ma, Y., Mitchell, B. S., & Rhoads, K. F. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0963 · Cited by 85
Selecting initial treatment of acute myeloid leukaemia in older adults
Podoltsev, N. A., Stahl, M. F., Zeidan, A. M., & Gore, S. D. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.09.005 · Cited by 85
Self-citationCosta, L. J., Brill, I. K., & Brown, E. E. (2016) · Cancer · doi:10.1002/cncr.30183 · Cited by 83
Occupational Electric and Magnetic Field Exposure and Leukemia
Kheifets, L., Afifi, A. A., Buffler, P. A., et al. (1997) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-199711000-00008 · Cited by 81
Acute Myeloid Leukemia Following Hodgkin Lymphoma: A Population-Based Study of 35 511 Patients
Schonfeld, S. J., Gilbert, E. S., Dores, G. M., Lynch, C. F., Hodgson, D. C., Hall, P. N., Storm, H. H., Andersen, A., Pukkala, ., Holowaty, E. J., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj017 · Cited by 80
Underreporting of Myeloid Malignancies by United States Cancer Registries
Craig, B. M., Rollison, D. E. M., List, A. F., & Cogle, C. R. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1087 · Cited by 76
Effects of Poverty and Race on Outcomes in Acute Myeloid Leukemia
Byrne, M. M., Halman, L. J., Koniaris, L. G., Cassileth, P. A., Rosenblatt, J. D., & Cheung, M. C. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181dea934 · Cited by 75
Cardoso, S. R., Ryan, G., Walne, A. J., Ellison, A., Lowe, R., Tummala, H., Rio‐Machín, A., Collopy, L. C., Seraihi, A. A., Wallis, Y., et al. (2016) · Leukemia · doi:10.1038/leu.2016.124 · Cited by 70
Li, S., Chen, L., Jin, W., Ma, X., Ma, Y., Dong, F., Zhu, H., Li, J., & Wang, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-18278-x · Cited by 68
Self-citationData quality in the Danish National Acute Leukemia Registry: a hematological data resource
Østgård, L. S. G., Nørgaard, M., Nørgaard, J. M., Severinsen, M. T., Sengeløv, H., Friis, L. S., Jensen, M. K., & Nielsen, O. J. (2013) · Clinical Epidemiology · doi:10.2147/clep.s48411 · Cited by 68
The incidence of acute myeloid leukemia in Calgary, Alberta, Canada: a retrospective cohort study
Shysh, A. C., Nguyen, L. T., Guo, M., Vaska, M. M., Naugler, C. T., & Rashid-Kolvear, F. (2017) · BMC Public Health · doi:10.1186/s12889-017-4644-6 · Cited by 68
Familial CEBPA-mutated acute myeloid leukemia
Tawana, K., Rio‐Machín, A., Preudhomme, C., & Fitzgibbon, J. (2017) · Seminars in Hematology · doi:10.1053/j.seminhematol.2017.04.001 · Cited by 66
Zeidan, A. M., Ali, N. E. A., Barnard, J., Padron, E., Lancet, J. E., Sekeres, M. A., Steensma, D. P., Dezern, A. E., Roboz, G. J., Jabbour, E. J., et al. (2017) · Leukemia · doi:10.1038/leu.2017.33 · Cited by 65
Self-citationRisk of Leukemia Among Survivors of Testicular Cancer: A Population-based Study of 42,722 Patients
Howard, R. A., Gilbert, E. S., Lynch, C. F., Hall, P. N., Storm, H. H., Holowaty, E. J., Pukkala, ., Langmark, F., Kaijser, M., Andersson, M., et al. (2008) · Annals of Epidemiology · doi:10.1016/j.annepidem.2008.01.003 · Cited by 63
Acute Granulocytic Leukemia Complicating Hodgkin's Disease
Steinberg, M. H. (1970) · Archives of Internal Medicine · doi:10.1001/archinte.1970.00310030106013 · Cited by 56
Bosshard, R., O’Reilly, K., Ralston, S., Chadda, S., & Cork, D. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.07.005 · Cited by 54
Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation
Renneville, A., Mialou, V., Philippe, N., Kagialis‐Girard, S., Biggio, V., Zabot, M.-T., Thomas, X., Bertrand, Y., & Preudhomme, C. (2008) · Leukemia · doi:10.1038/leu.2008.294 · Cited by 53
Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA 2 mutations
Mir, M. A., Kochuparambil, S. T., Abraham, R. S., Rodriguez, V., Howard, M. H., Hsu, A. P., Jackson, A. E., Holland, S. M., & Patnaik, M. M. (2015) · Cancer Medicine · doi:10.1002/cam4.384 · Cited by 53
Björk, J., Johansson, B., Bröberg, K., & Albin, M. C. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.10.009 · Cited by 52
Two novel germline DDX41 mutations in a family with inherited myelodysplasia/acute myeloid leukemia
Li, R., Sobreira, N., Witmer, P. D., Pratz, K. W., & Braunstein, E. M. (2016) · Haematologica · doi:10.3324/haematol.2015.139790 · Cited by 52
Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome
Watanabe, K. (2018) · Pediatrics International · doi:10.1111/ped.13776 · Cited by 52
Lorentino, F., Labopin, M., Bernardi, M., Ciceri, F., Socié, G., Cornelissen, J. J., Esteve, J., Ruggeri, A., Volin, L., Yakoub‐Agha, I., et al. (2018) · American Journal of Hematology · doi:10.1002/ajh.25231 · Cited by 49
De novo acute myeloid leukemia risk factors
Strom, S. S., Oum, R. E., Gbito, K. Y. E., Garcia‐Manero, G., & Yamamura, Y. (2012) · Cancer · doi:10.1002/cncr.27442 · Cited by 47
Leukemia and Hodgkin's Disease
Lacher, M. J., & SUSSMAN, L. N. (1963) · Annals of Internal Medicine · doi:10.7326/0003-4819-59-3-369 · Cited by 46
Cigarette smoking, cytogenetic abnormalities, and acute myelogenous leukemia
Lichtman, M. A. (2007) · Leukemia · doi:10.1038/sj.leu.2404698 · Cited by 46
Mawad, R., Gooley, T. A., Sandhu, V. K., Lionberger, J. M., Scott, B. L., Sandmaier, B. M., O’Donnell, P. V., Becker, P. S., Petersdorf, S. H., Dorcy, K. S., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.2567 · Cited by 46
Rosenstock, A. S., Niu, J., Giordano, S. H., Zhao, H., Wolff, A. C., & Chávez‐MacGregor, M. (2017) · Cancer · doi:10.1002/cncr.31144 · Cited by 44
Therapy-related myelodysplastic syndromes, or are they?
Zahr, A. A., Kavi, A. M., Mukherjee, S., & Zeidan, A. M. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.11.002 · Cited by 39
Self-citationBrunner, A. M., Blonquist, T. M., Sadrzadeh, H., Perry, A. M., Attar, E. C., Amrein, P. C., Ballen, K. K., Chen, Y., Neuberg, D. S., & Fathi, A. T. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.04.001 · Cited by 34
Østgård, L. S. G., Lund, J. L., Nørgaard, J. M., Nørgaard, M., Medeiros, B. C., Nielsen, B., Nielsen, O. J., Overgaard, U. M., Kallenbach, M., Marcher, C. W., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.10.019 · Cited by 33
Germline alterations in a consecutive series of acute myeloid leukemia
Wartiovaara‐Kautto, U., Hirvonen, E. A. M., Pitkänen, E., Heckman, C. A., Saarela, J., Kettunen, K., Porkka, K., & Kilpivaara, O. (2018) · Leukemia · doi:10.1038/s41375-018-0049-5 · Cited by 33
Finn, L. E., Sproat, L., Heckman, M. G., Jiang, L., Diehl, N. N., Ketterling, R. P., Tibes, R., Valdez, R., & Foran, J. M. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.09.003 · Cited by 32
Ojha, R. P., Fischbach, L. A., Zhou, Y., Felini, M., Singh, K. P., & Thertulien, R. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.04.003 · Cited by 30
Acute myeloid leukemia risk by industry and occupation
Tsai, R. J., Luckhaupt, S. E., Schumacher, P., Cress, R., Deapen, D., & Calvert, G. (2014) · Leukemia and Lymphoma · doi:10.3109/10428194.2014.894189 · Cited by 30
Rota, M., Porta, L., Pelucchi, C., Negri, E., Bagnardi, V., Bellocco, R., Corrao, G., Boffetta, P., & Vecchia, C. L. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.06.001 · Cited by 29
Gangatharan, S. A., Grove, C. S., P’ng, S., O'Reilly, J., Joske, D. J. L., Leahy, M. F., Threlfall, T. J., & Wright, M. P. (2013) · Internal Medicine Journal · doi:10.1111/imj.12169 · Cited by 28
Occupation, hobbies, and acute leukemia in adults
Terry, P., Shore, D., Rauscher, G. H., & Sandler, D. P. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.03.002 · Cited by 26
Molecular pathogenesis of AML: Translating insights to the clinic
Levine, R. L. (2013) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2013.10.003 · Cited by 22
Sinner, P. J., Cerhan, J. R., Folsom, A. R., & Ross, J. A. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0363 · Cited by 22
Østgård, L. S. G., Nørgaard, M., Sengeløv, H., Medeiros, B. C., Kjeldsen, L., Overgaard, U. M., Severinsen, M. T., Marcher, C. W., Jensen, M. K., & Nørgaard, J. M. (2016) · Oncotarget · doi:10.18632/oncotarget.12495 · Cited by 22
Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?
Stahl, M. F., Lu, B. Y., Kim, T. K., & Zeidan, A. M. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0503-8 · Cited by 22
Self-citationDechartres, A., Chevret, S., Lambert, J., Calvo, F. M., & Lévy, V. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq336 · Cited by 21
Clonal Hematopoiesis after Induction Chemotherapy for Acute Myeloid Leukemia
Steensma, D. P., & Ebert, B. L. (2018) · New England Journal of Medicine · doi:10.1056/nejme1802610 · Cited by 19
DeStefano, C. B., & Hourigan, C. S. (2018) · Therapeutic Advances in Hematology · doi:10.1177/2040620718761778 · Cited by 14
Future Prospects of Therapeutic Clinical Trials in Acute Myeloid Leukemia
Khan, M., Mansoor, A., & Kadia, T. M. (2016) · Future Oncology · doi:10.2217/fon-2016-0262 · Cited by 11
Relevance of clinical trials in acute myeloid leukaemia
Tsimberidou, A. M., & Estey, E. H. (2008) · Hematological Oncology · doi:10.1002/hon.851 · Cited by 7
Cited by
Zeidan, A. M., Boddu, P. C., Patnaik, M. M., Bewersdorf, J. P., Stahl, M., Rampal, R. K., Shallis, R., Steensma, D. P., Savona, M. R., Sekeres, M. A., et al. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30205-2 · Cited by 675
Self-citationIvosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia
Montesinos, P., Recher, C., Vives, S., Zarzycka, E., Wang, J., Bertani, G., Heuser, M., Calado, R. T., Schuh, A. C., Yeh, S.-P., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2117344 · Cited by 514
Yi, M., Li, A., Zhou, L., Chu, Q., Song, Y., & Wu, K. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00908-z · Cited by 309
Recent advances in targeted therapies in acute myeloid leukemia
Bhansali, R. S., Pratz, K. W., & Lai, C. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01424-6 · Cited by 275
Zeidan, A. M., Wang, R., Wang, X., Shallis, R. M., Podoltsev, N. A., Bewersdorf, J. P., Huntington, S. F., Neparidze, N., Giri, S., Gore, S. D., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001779 · Cited by 93
Self-citation
Metadata
- Authors
- Shallis, R. M., Wang, R., Davidoff, A., Ma, X., & Zeidan, A. M.
- Venue
- Blood Reviews
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 36
- Pages
- 70-87
- ISSN
- 0268-960X (ISSN-L)
- OpenAlex
- W2942855506
- Cited by
- 941
- References
- 138
- FWCI
- 52.73
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.